Amazon‘s (NSDQ:AMZN) Business division has dropped plans to sell and distribute pharmaceutical products to hospitals, according to a new report from CNBC.
The shift comes due to the online mega-retailer being unable to convince large hospital groups to change their purchasing process and break existing deals and relationships with distributors, according to the report.
Read the whole report on our sister site, Drug Delivery Business
The post Report: Amazon abandons drug distribution and supply plans appeared first on MassDevice.